180 related articles for article (PubMed ID: 36251796)
1. Serum IGF-1 to IGFBP-3 Molar Ratio: A Promising Diagnostic Tool for Growth Hormone Deficiency in Children.
Haj-Ahmad LM; Mahmoud MM; Sweis NWG; Bsisu I; Alghrabli AM; Ibrahim AM; Zayed AA
J Clin Endocrinol Metab; 2023 Mar; 108(4):986-994. PubMed ID: 36251796
[TBL] [Abstract][Full Text] [Related]
2. The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children.
Haghshenas Z; Sotoudeh K; Karamifar H; Karamizadeh Z; Amirhakimi G
Indian J Pediatr; 2009 Jul; 76(7):699-703. PubMed ID: 19381505
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
4. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
Inoue-Lima TH; Vasques GA; Nakaguma M; Brito LP; Mendonça BB; Arnhold IJP; Jorge AAL
Horm Res Paediatr; 2020; 93(3):197-205. PubMed ID: 32799208
[TBL] [Abstract][Full Text] [Related]
6. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population.
Granada ML; Murillo J; Lucas A; Salinas I; Llopis MA; Castells I; Foz M; Sanmartí A
Eur J Endocrinol; 2000 Mar; 142(3):243-53. PubMed ID: 10700718
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
9. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency.
Ertl DA; Chen J; Gleiss A; Janu D; Sagmeister S; Raimann A; Riedl S; Haeusler G
Horm Res Paediatr; 2020; 93(6):371-379. PubMed ID: 33341813
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
Juul A; Skakkebaek NE
J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency.
Hasegawa Y; Hasegawa T; Aso T; Kotoh S; Nose O; Ohyama Y; Araki K; Tanaka T; Saisyo S; Yokoya S
Eur J Endocrinol; 1994 Jul; 131(1):27-32. PubMed ID: 7518726
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children].
Codner E; Méricq V; Ugarte F; Iñíguez G; Espinoza M; Avila A; Salazar T; Cassorla F; García H
Rev Med Chil; 1999 Jul; 127(7):807-13. PubMed ID: 10668288
[TBL] [Abstract][Full Text] [Related]
16. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
17. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia.
Chrysis DC; Alexandrides TK; Koromantzou E; Georgopoulos N; Vassilakos P; Kiess W; Kratsch J; Beratis NG; Spiliotis BE
Clin Endocrinol (Oxf); 2001 Feb; 54(2):253-9. PubMed ID: 11207641
[TBL] [Abstract][Full Text] [Related]
18. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
19. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of idiopathic growth hormone deficiency: contributions of data on the acid-labile subunit, insulin-like growth factor (IGF)-I and-II, and IGF binding protein-3.
Trivin C; Souberbielle JC; Aubertin G; Lawson-Body E; Adan L; Brauner R
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):481-9. PubMed ID: 16759033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
